Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Changhu Chen"'
Autor:
Basel Altoos, Justin M. Honce, Chad G. Rusthoven, Timothy V. Waxweiler, Laurie E. Gaspar, Changhu Chen, D. Ryan Ormond, Douglas E. Ney, Denise Damek, Arya Amini, Arthur K. Liu, Sana D. Karam, Brian D. Kavanagh, Kevin O. Lillehei
Publikováno v:
Journal of Radiation Oncology. 5:33-39
Glioblastoma multiforme (GBM) is a nearly uniformly fatal brain tumor with a median recurrence rate of 7 months and survival of 14 months after multimodality treatment. We sought to evaluate outcomes based on the presence or absence of symptoms at th
Publikováno v:
Journal of Applied Clinical Medical Physics
Variations in daily setup and rectum/bladder filling lead to uncertainties in the delivery of prostate IMRT. The purpose of this study is to determine the optimal PTV margin for CBCT‐guided prostate IMRT based on daily CBCT dose calculations using
Autor:
Denise Damek, Douglas E. Ney, Bette K. Kleinschmidt-DeMasters, Julie A. Carlson, Brian D. Kavanagh, Changhu Chen, Kevin O. Lillehei, Laurie E. Gaspar, Krishna Reddy, Allen Waziri
Publikováno v:
Journal of Neuro-Oncology. 122:135-143
Bevacizumab blocks the effects of VEGF and may allow for more aggressive radiotherapy schedules. We evaluated the efficacy and toxicity of hypofractionated intensity-modulated radiation therapy with concurrent and adjuvant temozolomide and bevacizuma
Autor:
Changhu Chen
Publikováno v:
Clinical Radiation Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad89a1aba7a966a4eede2e70fb9e5d22
https://doi.org/10.1002/9781119341154.ch11
https://doi.org/10.1002/9781119341154.ch11
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 58:714-721
Introduction The objective of this study was to report the patterns of failure in patients with glioblastoma multiforme (GBM) treated on a phase II trial of hypofractionated intensity-modulated radiotherapy (hypo-IMRT) with concurrent and adjuvant te
Autor:
Changhu Chen, Denise Damek, Laurie E. Gaspar, Brian D. Kavanagh, Douglas E. Ney, Krishna Reddy, Kevin O. Lillehei, Allen Waziri
Publikováno v:
Journal of Neuro-Oncology. 114:111-116
To report health-related quality of life (HRQOL) in glioblastoma (GBM) patients treated on a phase II trial of hypofractionated intensity-modulated radiotherapy (hypo-IMRT) with temozolomide (TMZ). GBM patients received postoperative hypo-IMRT to 60
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 57:349-355
Introduction Despite the emergence of new imaging technologies, the differentiation of treatment-related changes from recurrent tumour in patients with high-grade gliomas remains a difficult challenge. We evaluated whether specific MRI (magnetic reso
Publikováno v:
The Laryngoscope. 122:2736-2742
Objectives/Hypothesis: To evaluate the effect of larynx and esophageal inlet sparing on dysphagia recovery after intensity-modulated radiotherapy (IMRT) for stage III-IV oropharyngeal squamous cell carcinoma. Study Design: Retrospective study. Method
Autor:
Laurie E. Gaspar, Emma C. Fields, Allen Waziri, Changhu Chen, Denise Damek, Brian D. Kavanagh, Arthur K. Liu, Kevin O. Lillehei
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 82:51-57
Purpose To determine the maximum tolerated dose (MTD) of vandetanib with fractionated stereotactic radiosurgery (SRS) in patients with recurrent malignant gliomas. Methods and Materials Patients with a recurrent malignant glioma and T1-enhancing recu
Publikováno v:
Practical Radiation Oncology. 2:63-72
Non-melanoma skin cancers are the most common cutaneous malignancies, with over 1 million cases in the year 2010.1,2 Approximately 80% of non-melanoma skin cancers are basal-cell carcinomas, and 20% are squamouscell carcinomas.3 Although the mortalit